logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 1
  • 1
    Akrami, Nariman
    Born in September 1986
    Individual (7 offsprings)
    Officer
    2014-05-19 ~ now
    OF - Director → CIF 0
    Mr Nariman Akrami
    Born in September 1986
    Individual (7 offsprings)
    Person with significant control
    2016-04-08 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
    Mr Nariman Akrami
    Born in June 1986
    Individual (7 offsprings)
    Person with significant control
    2019-03-10 ~ 2019-06-01
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
parent relation
Company in focus

MAYFAIR PHARMACEUTICALS LIMITED

Period: 2014-05-19 ~ now
Company number: 09045376
Registered name
MAYFAIR PHARMACEUTICALS LIMITED - now
Standard Industrial Classification
47910 - Retail Sale Via Mail Order Houses Or Via Internet
Brief company account
Property, Plant & Equipment
6,730 GBP2025-03-31
5,146 GBP2024-03-31
Total Inventories
63,462 GBP2025-03-31
79,278 GBP2024-03-31
Debtors
478,988 GBP2025-03-31
658,193 GBP2024-03-31
Cash at bank and in hand
168,872 GBP2025-03-31
676,243 GBP2024-03-31
Current Assets
711,322 GBP2025-03-31
1,413,714 GBP2024-03-31
Creditors
Amounts falling due within one year
-457,639 GBP2025-03-31
-1,093,592 GBP2024-03-31
Net Current Assets/Liabilities
253,683 GBP2025-03-31
320,122 GBP2024-03-31
Total Assets Less Current Liabilities
260,413 GBP2025-03-31
325,268 GBP2024-03-31
Creditors
Amounts falling due after one year
-86,454 GBP2025-03-31
-185,427 GBP2024-03-31
Net Assets/Liabilities
173,959 GBP2025-03-31
139,841 GBP2024-03-31
Equity
Called up share capital
100 GBP2025-03-31
100 GBP2024-03-31
Retained earnings (accumulated losses)
173,859 GBP2025-03-31
139,741 GBP2024-03-31
Equity
173,959 GBP2025-03-31
139,841 GBP2024-03-31
Average Number of Employees
42024-04-01 ~ 2025-03-31
22023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Gross Cost
13,175 GBP2025-03-31
9,909 GBP2024-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
6,445 GBP2025-03-31
4,763 GBP2024-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
1,682 GBP2024-04-01 ~ 2025-03-31

  • MAYFAIR PHARMACEUTICALS LIMITED
    Info
    Registered number 09045376
    34 South Molton Street, London W1K 5RG
    PRIVATE LIMITED COMPANY incorporated on 2014-05-19 (12 years 2 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-08-13
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.